SANOFIFLU.COM: Keyword Density Checker

Total words: 2509 | 2-word phrases: 627 | 3-word phrases: 741 | 4-word phrases: 816

PAGE INFO

Title	Try to keep the title under 60 characters (71 characters) Trivalent Influenza Vaccines for Influenza Type A and B \| Sanofiflu.com
Description	Try to keep the meta description between 50 - 160 characters (218 characters) Sanofi offers a range of trivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype & type B virus. Please see Important Safety Information or Prescribing Information.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	years of age	15	2.02%
2	the most common	12	1.62%
3	age and older	10	1.35%
4	of age and	10	1.35%
5	reaction was pain	8	1.08%
6	or fluzone highdose	7	0.94%
7	solicited systemic adverse	7	0.94%
8	systemic adverse reactions	7	0.94%
9	adverse reactions were	7	0.94%
10	65 years of	7	0.94%
11	adverse reaction was	6	0.81%
12	site adverse reaction	6	0.81%
13	approved for use	6	0.81%
14	and fluzone highdose	5	0.67%
15	most common injection	5	0.67%
16	fluzone flublok or	5	0.67%
17	flublok or fluzone	5	0.67%
18	common solicited systemic	5	0.67%
19	age the most	5	0.67%
20	of age the	5	0.67%
21	most common solicited	5	0.67%
22	most common ≥10	4	0.54%
23	was pain the	4	0.54%
24	pain the most	4	0.54%
25	injectionsite adverse reaction	4	0.54%
26	for use in	4	0.54%
27	in persons 6	4	0.54%
28	randomized controlled trial	4	0.54%
29	in adults 65	4	0.54%
30	reactions were headache	4	0.54%

#	Keyword	Frequency	Density
1	of age and older	10	1.23%
2	years of age and	8	0.98%
3	65 years of age	7	0.86%
4	adverse reaction was pain	6	0.74%
5	systemic adverse reactions were	6	0.74%
6	solicited systemic adverse reactions	6	0.74%
7	of age the most	5	0.61%
8	fluzone flublok or fluzone	5	0.61%
9	flublok or fluzone highdose	5	0.61%
10	the most common solicited	5	0.61%
11	the most common injection	5	0.61%
12	site adverse reaction was	5	0.61%
13	years of age the	5	0.61%
14	approved for use in	4	0.49%
15	is approved for use	4	0.49%
16	was pain the most	4	0.49%
17	in adults 65 years	4	0.49%
18	adults 65 years of	4	0.49%
19	reaction was pain the	4	0.49%
20	the most common injectionsite	4	0.49%
21	common solicited systemic adverse	4	0.49%
22	most common solicited systemic	4	0.49%
23	age the most common	4	0.49%
24	≥10 solicited systemic adverse	3	0.37%
25	age and older fluzone	3	0.37%
26	flublok and fluzone highdose	3	0.37%
27	adverse reactions were headache	3	0.37%
28	for use in persons	3	0.37%
29	pain the most common	3	0.37%
30	common injectionsite adverse reaction	3	0.37%
31	common ≥10 solicited systemic	3	0.37%
32	8 years of age	3	0.37%
33	most common injectionsite adverse	3	0.37%
34	injectionsite adverse reaction was	3	0.37%
35	for the prevention of	2	0.25%
36	vaccines indicated for active	2	0.25%
37	are vaccines indicated for	2	0.25%
38	fluzone highdose are vaccines	2	0.25%
39	and fluzone highdose are	2	0.25%
40	the prevention of disease	2	0.25%

#	URL	Whois	Check
1	https://www.vaccineshoppe.com/fluzonehighdosePI	Whois	vaccineshoppe.com
2	https://www.vaccineshoppe.com/flublokPI	Whois	vaccineshoppe.com
3	https://www.vaccineshoppe.com/fluzonePI	Whois	vaccineshoppe.com
4	https://www.vaccineshoppe.com/fluzonePI	Whois	vaccineshoppe.com
5	https://www.vaccineshoppe.com/fluzonePI	Whois	vaccineshoppe.com
6	https://www.vaccineshoppe.com/flublokPI	Whois	vaccineshoppe.com
7	https://www.vaccineshoppe.com/fluzonehighdosePI	Whois	vaccineshoppe.com
8	https://www.vaccineshoppe.com/fluzonePIS	Whois	vaccineshoppe.com
9	https://www.vaccineshoppe.com/fluzonehighdosePIS	Whois	vaccineshoppe.com
10	https://www.sanofi.com/en/our-responsibility/healthcare-for-all/fighting-against-falsified-medicine	Whois	sanofi.com